This is a past event
Athersys hosted a business update conference call on August 9, 2023 at 4:30 p.m. Eastern Time. Dan Camardo, Chief Executive Officer, Maia Hansen, Chief Operating Officer, Kasey Rosado, Interim Chief Financial Officer, and Willie Mays, Executive Vice President of Regenerative Medicine and Head of Neuroscience, provided an overview of the Company’s recent clinical and operational progress and discuss timing to conduct an interim analysis with MASTERS-2, a Phase 3 pivotal trial of MultiStem treatment in ischemic stroke.
REPLAY INFORMATION
Toll Free Dial in Number: 1-800-770-2030
Toll Dial in Number: 1-647-362-9199
Conference ID: 70781
Encore Replay Dates: 08/09/2023 – 08/16/2023 23:59 ET